HLTH - VanEck Vectors Global Healthcare Leaders ETF

VanEck Blog & Insights

VanEck Vectors Global Healthcare Leaders ETF HLTH

Fund description: HLTH gives investors exposure to a diversified portfolio of the largest international companies from the global healthcare sector. HLTH aims to provide investment returns before fees and other costs which track the performance of the Index. 

Index description: The MarketGrader Developed Markets (ex-Australia) Health Care Index consists of 50 fundamentally sound companies with the best growth at a reasonable price (GARP) attributes in the healthcare sector from developed markets excluding Australia.

Management style:  Replication

 as at 21-Sep-20

  • Exchange

    ASX
  • ASX code

    HLTH
  • Bloomberg index code

    MGHCAUNR
  • Index provider

    MarketGrader
  • NAV1

    $10.10
  • Units outstanding1

    600,000
  • Net assets1

    $6.1M
  • Number of holdings1

    50
  • Inception date2

    08-Sep-20
  • ASX commencement

    10-Sep-20
1As of the close of the previous trading day.
2The date the ETF was seeded prior to quotation on ASX.

as at 21-Sep-20

*The NAV is generally calculated daily after all markets are closed for that day based on the closing price of the securities on the relevant foreign stock exchange. The NAV is then converted to AUD based on the relevant London WM Reuters 4pm exchange rate. This means, due to Australia’s time zone, that the NAV will generally not be updated until around 12pm next business day. 

 

Key benefits

Global growth opportunity
A sector with significant growth potential due to shifting global demographics, social changes, research & development and innovation supporting increased demand in healthcare-related products and services

A portfolio of global healthcare leaders comprising the most fundamentally strong companies
Invests in 50 fundamentally sound and attractively valued companies with the best growth prospects in the healthcare sector

Targeted exposure and diversification
A portfolio which targets focused exposure to healthcare and offers true diversification by equally weighting across companies

Trading information

  • ASX code

    HLTH
  • IRESS code

    HLTH.AXW
  • Units outstanding

    600,000
  • ISIN

    AU0000102683

Fees and other costs  

  • Management costs p.a.

    0.45%

Key risks

An investment in the ETF carries risks associated with: ASX trading time differences, financial markets generally, individual company management, industry sectors, foreign currency, currency hedging, country or sector concentration, political, regulatory and tax risks, fund operations, liquidity and tracking an index. See the PDS for details.

Prices as at  21-Sep-20

NAV/
Last trade
Volume:
30-day avg/
Previous day
Daily change: NAV/
Last trade
YTD change:
NAV/
Last trade
Premium/
Discount
Premium/
Discount
Distribution charts
NAV &
Premium /Discount
History
NAV
Chart
HLTH $10.10
$10.09
0
65,591
$0.00 / -0.04%
$-0.04 / -0.39%
+1.54%
--
$-0.01
-0.10%

Performance history (%) View all ETFs » View all indices »

1 Mth 3 Mths 6 Mths 1 Yr 3 Yrs p.a. 5 Yrs p.a. 10 Yrs p.a. ETF Inception p.a.
Price return -- -- -- -- -- -- -- --
Income return -- -- -- -- -- -- -- --
Total return -- -- -- -- -- -- -- --
Index (MGHCAUNR) -0.73 -2.24 12.62 26.47 22.41 16.04 21.54 --
1 Mth 3 Mths 6 Mths 1 Yr 3 Yrs p.a. 5 Yrs p.a. 10 Yrs p.a. ETF Inception p.a.
Price return -- -- -- -- -- -- -- --
Income return -- -- -- -- -- -- -- --
Total return -- -- -- -- -- -- -- --
Index (MGHCAUNR) -2.32 8.15 15.53 31.02 22.02 17.22 20.99 --

Top ten holdings (%) View all daily holdings » as at 18-Sep-20

No. of holdings: 50
Holding name
Ticker
No. of securities held Market value % of Fund
net assets
ALIGN TECHNOLOGY INC
ALGN US
418 183,625 3.03
WEST PHARMACEUTICAL SERVICES
WST US
447 169,911 2.80
SARTORIUS STEDIM BIOTECH
DIM FP
346 168,377 2.78
GENMAB A/S
GMAB DC
314 166,610 2.75
IDEXX LABORATORIES INC
IDXX US
315 152,945 2.52
LONZA GROUP AG-REG
LONN SW
175 150,653 2.49
HUMANA INC
HUM US
269 148,234 2.45
INTUITIVE SURGICAL INC
ISRG US
157 140,867 2.32
UCB SA
UCB BB
868 139,486 2.30
ONO PHARMACEUTICAL CO LTD
4528 JP
3,100 137,095 2.26
Top ten total (%) 25.70
These are not recommendations to buy or to sell any security.

Top 10 Country weightings (%) as at 21-Sep-20

  • Country

    Weightings (%)
  • United States

    52.0
  • Japan

    19.3
  • Denmark

    8.1
  • Switzerland

    6.8
  • France

    4.4
  • China

    3.6
  • Belgium

    2.3
  • New Zealand

    1.8
  • United Kingdom

    1.6
  • Other/Cash

    0.0
  • Total

    99.9

Sub-sector weightings (%) as at 21-Sep-20

  • Sector

    Weightings (%)
  • Pharmaceuticals, Biotechnology

    55.4
  • Health Care Equipment & Services

    40.9
  • Materials

    2.0
  • Consumer Durables & Apparel

    1.6
  • Other/Cash

    0.0
  • Total

    99.9